February 26, 2015 6:33 PM ET

Pharmaceuticals

Company Overview of Cetek Corporation

Company Overview

Cetek Corporation, a biopharmaceutical company, engages in the discovery and development of novel cancer therapeutics. Its products include CTK110, a small molecule that shows in vitro and initial in vivo anticancer activity; CTK-100144, which has potent activity in in vitro biochemical and cell-based assays; and CTK-100147 small molecules with highly selective and low nano-molar potency against the chymotrypsin. The company also provides contract services and discovery collaborations for various targets and therapeutic areas. Cetek Corporation was formerly known as H & K, Inc. and changed its name to Cetek Corporation in 1998. The company was founded in 1996 and is headquartered in Marlboro...

260 Cedar Hill Street

Marlborough, MA 01752-3017

United States

Founded in 1996

Phone:

508-229-8900

Fax:

508-229-2344

Key Executives for Cetek Corporation

Chief Executive Officer, President and Director
Co-Founder and Chairman of Scientific Advisory board
Co-Founder and Senior Vice President of Technology
Age: 58
Senior Vice President of Operations
Senior Vice President of Business Development
Age: 73
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
DSM Pharma Chemicals United States
Angelini Pharma, Inc. United States
LaRon Pharma Inc. United States
Acpharis Inc. United States
Whole Health Products, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cetek Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.